Bio
Michael Ferrante is the Executive Director, Business Analytics, Global Regulatory and Clinical Safety (GRACS) within Merck Research Labs. In this role, Mike is responsible for tracking and analyzing time reporting effort, forecasting resources for 1-5 years, prioritizing the portfolio execution, driving data science applications, and aligning budget, metrics, objectives, and dashboards for the 2400-person global organization.
Prior to re-joining Merck in 2020, Mike was at Bristol Myers Squibb, where he led the R&D project, portfolio, clinical study management and headcount planning capabilities. Before joining BMS, he served as Managing Director of Consulting Solutions at YourEncore. Mike previously worked at Merck, where he was Senior Director, Business Operations, supporting clinical grants planning and budgeting, functional objectives development and execution, and strategic analysis for global clinical development and regulatory. He also led R&D operations for Merck’s subsidiary in Japan.
Mike earned a B.S. in Chemical Engineering from the University of Michigan, an M.S. in Chemical Engineering from Carnegie Mellon University and an MBA from the University of Michigan. He is currently pursuing a Masters in Public Health at Rutgers University. He lives in Cranbury, New Jersey, with his wife Deanna and has two grown children.